
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Obeticholic acid for the treatment of nonalcoholic steatohepatitis : comparative clinical effectiveness and value : evidence report</dc:title>
  <dc:creator>Pearson, Steven D. author</dc:creator>
  <dc:creator>Banken, Reiner, author.</dc:creator>
  <dc:creator>Chapman, Rick M., author.</dc:creator>
  <dc:creator>Russo, Elizabeth T. author.</dc:creator>
  <dc:creator>Loos, Anne M. author.</dc:creator>
  <dc:creator>Emond, Sarah K., author.</dc:creator>
  <dc:creator>Segel, Celia S., author.</dc:creator>
  <dc:creator>Ollendorf, Daniel A., author.</dc:creator>
  <dc:creator>Chhatwal, Jagpreet, author.</dc:creator>
  <dc:creator>Hur, Chin, author.</dc:creator>
  <dc:creator>Klebanoff, Matthew, author.</dc:creator>
  <dc:creator>Samur, Sumeyye K., author.</dc:creator>
  <dc:subject>Bile Acids and Salts -- agonists</dc:subject>
  <dc:subject>Comparative Effectiveness Research</dc:subject>
  <dc:subject>Fatty Liver -- drug therapy</dc:subject>
  <dc:publisher>Boston, MA : Institute for Clinical and Economic Review, July 26, 2016</dc:publisher>
  <dc:contributor>Institute for Clinical and Economic Review, issuing body.</dc:contributor>
  <dc:contributor>New England Comparative Effectiveness Public Advisory Council, issuing body.</dc:contributor>
  <dc:type>Technical Report</dc:type>
  <dc:format>Text</dc:format>
  <dc:format>Illustrations</dc:format>
  <dc:format>1 online resource (1 PDF file (vi, ES10, 69 pages))</dc:format>
  <dc:identifier>nlm:nlmuid-101704677-pdf</dc:identifier>
  <dc:identifier>101704677</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101704677</dc:identifier>
  <dc:language>English</dc:language>
  <dc:coverage>United States</dc:coverage>
  <dc:rights>Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. http://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>
